|
1
|
Blay JY, El Sayadi H, Thiesse P, Garret J
and Ray-Coquard I: Complete response to imatinib in relapsing
pigmented villonodular synovitis/tenosynovial giant cell tumor
(PVNS/TGCT). Ann Oncol. 19:821–822. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gu HF, Zhang SJ, Zhao C, Chen Y and Bi Q:
A comparison of open and arthroscopic surgery for treatment of
diffuse pigmented villonodular synovitis of the knee. Knee Surg
Sports Traumatol Arthrosc. 22:2830–2836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ottaviani S, Ayral X, Dougados M and
Gossec L: Pigmented villonodular synovitis: A retrospective
single-center study of 122 cases and review of the literature.
Semin Arthritis Rheum. 40:539–546. 2011. View Article : Google Scholar
|
|
4
|
Lavrador JP, Oliveira E, Gil N, Francisco
AF and Livraghi S: C1-C2 pigmented villonodular synovitis and clear
cell carcinoma: Unexpected presentation of a rare disease and a
review of the literature. Eur Spine J. 24(Suppl 4): S465–S471.
2015. View Article : Google Scholar
|
|
5
|
Myers BW, Masi AT and Feigenbaum SL:
Pigmented villo-nodular synovitis and tenosynovitis: A clinical
epidemiologic study of 166 cases and literature review. Medicine.
59:223–238. 1980.
|
|
6
|
West RB, Rubin BP, Miller MA, Subramanian
S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A,
Downs-Kelly E, et al: A landscape effect in tenosynovial giant-cell
tumor from activation of CSF1 expression by a translocation in a
minority of tumor cells. Proc Natl Acad Sci USA. 103:690–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nassar WA, Bassiony AA and Elghazaly HA:
Treatment of diffuse pigmented villonodular synovitis of the knee
with combined surgical and radiosynovectomy. HSS J. 5:19–23. 2009.
View Article : Google Scholar :
|
|
8
|
Fiocco U, Sfriso P, Lunardi F, Pagnin E,
Oliviero F, Scagliori E, Cozzi L, Vezzù M, Molena B, Scanu A, et
al: Molecular pathways involved in synovial cell inflammation and
tumoral proliferation in diffuse pigmented villonodular synovitis.
Autoimmun Rev. 9:780–784. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bertoni F, Unni KK, Beabout JW and Sim FH:
Malignant giant cell tumor of the tendon sheaths and joints
(malignant pigmented villonodular synovitis). Am J Surg Pathol.
21:153–163. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Imakiire N, Fujino T, Morii T, Honya K,
Mochizuki K, Satomi K and Fujioka Y: Malignant pigmented
villonodular synovitis in the knee - report of a case with rapid
clinical progression. Open Orthop J. 5:13–16. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaneko K, Nakahara D, Tobe M, Iwase H,
Inoue Y, Ohbayashi O and Kurosawa H: Pigmented villonodular
synovitis of the ankle in an adolescent. Int Orthop. 24:234–237.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park G, Kim YS, Kim JH, Lee SW, Song SY,
Choi EK, Yi SY and Ahn SD: Low-dose external beam radiotherapy as a
postoperative treatment for patients with diffuse pigmented
villonodular synovitis of the knee: 4 recurrences in 23 patients
followed for mean 9 years. Acta Orthop. 83:256–260. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Snoots WM, Watkins D, Dockery D, Mennel R
and Cheek BS: Pigmented villonodular synovitis responsive to
imatinib therapy. Proc. 24:134–138. 2011.
|
|
14
|
Ray RA, Morton CC, Lipinski KK, Corson JM
and Fletcher JA: Cytogenetic evidence of clonality in a case of
pigmented villonodular synovitis. Cancer. 67:121–125. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen WM, Wu PK and Liu CL: Simultaneous
anterior and posterior synovectomies for treating diffuse pigmented
villonodular synovitis. Clin Orthop Relat Res. 470:1755–1762. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakahara H, Matsuda S, Harimaya K,
Sakamoto A, Matsumoto Y, Okazaki K, Tashiro Y and Iwamoto Y:
Clinical results of open synovectomy for treatment of diffuse
pigmented villonodular synovitis of the knee: Case series and
review of literature. Knee. 19:684–687. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishida Y, Tsukushi S, Nakashima H,
Sugiura H, Yamada Y, Urakawa H, Arai E and Ishiguro N:
Osteochondral destruction in pigmented villonodular synovitis
during the clinical course. J Rheumatol. 39:345–351. 2012.
View Article : Google Scholar
|
|
18
|
Liu XY, Yang YF, Wu CT, Xiao FJ, Zhang QW,
Ma XN, Li QF, Yan J, Wang H and Wang LS: Spred2 is involved in
imatinib-induced cytotoxicity in chronic myeloid leukemia cells.
Biochem Biophys Res Commun. 393:637–642. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cassier PA, Gelderblom H, Stacchiotti S,
Thomas D, Maki RG, Kroep JR, van der graaf WT, Italiano A, Seddon
B, Dômont J, et al: Efficacy of imatinib mesylate for the treatment
of locally advanced and/or metastatic tenosynovial giant cell
tumor/pigmented villonodular synovitis. Cancer. 118:1649–1655.
2012. View Article : Google Scholar
|
|
20
|
Ravi V, Wang WL and Lewis VO: Treatment of
tenosynovial giant cell tumor and pigmented villonodular synovitis.
Curr Opin Oncol. 23:361–366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stacchiotti S, Crippa F, Messina A,
Pilotti S, Gronchi A, Blay JY and Casali PG: Response to imatinib
in villonodular pigmented synovitis (PVNS) resistant to nilotinib.
Clin Sarcoma Res. 3:82013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zimmermann T, Kunisch E, Pfeiffer R, Hirth
A, Stahl HD, Sack U, Laube A, Liesaus E, Roth A, Palombo-Kinne E,
et al: Isolation and characterization of rheumatoid arthritis
synovial fibroblasts from primary culture - primary culture cells
markedly differ from fourth-passage cells. Arthritis Res. 3:72–76.
2001. View Article : Google Scholar :
|
|
23
|
Wessel D and Flügge UI: A method for the
quantitative recovery of protein in dilute solution in the presence
of detergents and lipids. Anal Biochem. 138:141–143. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Granowitz SP, D'Antonio J and Mankin HL:
The pathogenesis and long-term end results of pigmented
villonodular synovitis. Clin Orthop Relat Res. 114:335–351.
1976.PubMed/NCBI
|
|
25
|
Schwartz HS, Unni KK and Pritchard DJ:
Pigmented villonodular synovitis. A retrospective review of
affected large joints. Clin Orthop Relat Res. 247:243–255.
1989.PubMed/NCBI
|
|
26
|
Tyler WK, Vidal AF, Williams RJ and Healey
JH: Pigmented villonodular synovitis. J Am Acad Orthop Surg.
14:376–385. 2006.PubMed/NCBI
|
|
27
|
Dines JS, DeBerardino TM, Wells JL, Dodson
CC, Shindle M, DiCarlo EF and Warren RF: Long-term follow-up of
surgically treated localized pigmented villonodular synovitis of
the knee. Arthroscopy. 23:930–937. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guilhot F: Indications for imatinib
mesylate therapy and clinical management. Oncologist. 9:271–281.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sawyers CL: Imatinib GIST keeps finding
new indications: Successful treatment of dermatofibrosarcoma
protuberans by targeted inhibition of the platelet-derived growth
factor receptor. J Clin Oncol. 20:3568–3569. 2002.PubMed/NCBI
|
|
30
|
Du Y, Wang K, Fang H, Li J, Xiao D, Zheng
P, Chen Y, Fan H, Pan X, Zhao C, et al: Coordination of intrinsic,
extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib
mesylate combined with arsenic trioxide in chronic myeloid
leukemia. Blood. 107:1582–1590. 2006. View Article : Google Scholar
|
|
31
|
Hu Q, Wu D, Chen W, Yan Z, Yan C, He T,
Liang Q and Shi Y: Molecular determinants of caspase-9 activation
by the Apaf-1 apoptosome. Proc Natl Acad Sci USA. 111:16254–16261.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo X, Budihardjo I, Zou H, Slaughter C
and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c
release from mitochondria in response to activation of cell surface
death receptors. Cell. 94:481–490. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mutlu A, Gyulkhandanyan AV, Freedman J and
Leytin V: Activation of caspases-9, -3 and -8 in human platelets
triggered by BH3-only mimetic ABT-737 and calcium ionophore A23187:
Caspase-8 is activated via bypass of the death receptors. Br J
Haematol. 159:565–571. 2012.PubMed/NCBI
|
